Capt. Chaos

It's all about mindset. Shares are stepping stones to your goal. Looking for the next bagger. Tweets are my opinion only. DYOR

[Capt. Chaos @AndrewDigby3]

@MBdaytrading Explains a lot MB

[Capt. Chaos @AndrewDigby3]

@MBdaytrading Morning MB, that’s an understatement mate, so much excellent work being done yet the sp doesn’t reflect it at all. Good luck MB

[Capt. Chaos @AndrewDigby3]

@MBdaytrading Hi MB, I guess you are now out for the time being? Any chance you could let me know where support lines are please?

[Capt. Chaos @AndrewDigby3]

@Red7Finance Not the point Eddie

[Capt. Chaos @AndrewDigby3]

3% drop, can’t make this shit up!! One day we’ll get the right response from such incredible data! #avct

[Capt. Chaos @AndrewDigby3]

@BreakoutCV #AVCT, without doubt

[Capt. Chaos @AndrewDigby3]

@tom_the_bomb__ Another nice find Tom, hoping tomorrow will be another great day for SH’s, red dot at 7 🤞#AVCT

[Capt. Chaos @AndrewDigby3]

@hypergrowth102 #AVCT U.K. AIM exchange

[Capt. Chaos @AndrewDigby3]

At last the MM’s have closed the spread a little, in the right direction #avct

[Capt. Chaos @AndrewDigby3]

@Jonno981 Hi Jonno, check out this post from Myles 3 days ago , it’s a real eye opener as to what value #AVCT could be worth

[Myles McNulty @MylesMcNulty]

Hi Josh, I don't have any selling levels on #AVCT for my core holding, as I think the upside is, for all intents and purposes, unlimited now from a $460m mkt cap.

AVA6103 could be a $40, $50, $60 billion per annum drug - and that's just if the pre-clinical data is matched in the clinic.

There is almost every reason to think that it will in fact be surpassed, as was pointed out by @avacta during the recent Science Day.

Big Pharma is paying what, 3-6x peak sales for acquirees' lead candidate?

And in my view, 6103 is considerably more derisked than most seem to think.

To revert to your question: my target is to hold until an offer is accepted by >75% of shareholders, and I'm forced to sell!

But given how many retail holders - which makes up >95% of the register - is invested fully (not just capital-wise but sentimentally too), I think the final price that the likes of AstraZeneca, Novartis, Merck etc. will have to pay will be incredibly high.

P.S. selloff today is almost certainly due to a dozen or so traders exiting in order to chase MKA and IES. All very predictable. Alas, nothing to be done (except of course take advantage of the dip, if one has spare capital! N.B. not investment advice blah blah blah! 😂).

[Capt. Chaos @AndrewDigby3]

@Livinginthesurf @tom_the_bomb__ @STWpharma Not long to wait Surfy

[Capt. Chaos @AndrewDigby3]

@Livinginthesurf @tom_the_bomb__ @STWpharma What’s your thoughts Surfy, later this year or early next?

[Capt. Chaos @AndrewDigby3]

@tom_the_bomb__ #AVCT

[Capt. Chaos @AndrewDigby3]

@MBdaytrading Ok, but if our market is closed how do they trade? Sorry mate above my understanding

[Capt. Chaos @AndrewDigby3]

@MBdaytrading @Borg74 Thank you MB, a much brighter picture than the past year

[Capt. Chaos @AndrewDigby3]

@tom_the_bomb__ And we should get that validation in the not too distant future Tom, not long to wait considering how long we have been here imo #AVCT

[Capt. Chaos @AndrewDigby3]

@MBdaytrading I’ve done a search MB but can’t find any info regarding this, where did you see this mate?